RSS-Feed abonnieren
PDF herunterladen
DOI: 10.4103/ijmpo.ijmpo_238_19
Hypothalamic-Pituitary Axis Dysfunction and Metabolic Derangements in Thai Childhood Leukemia Survivors
Financial support and sponsorship Nil.
Abstract
Aims: To determine the prevalence and severity of endocrine and metabolic derangements in childhood-onset ALL survivors from Thailand and to describe the associated risk factors. Settings and Design: Paediatric department in medical school hospital, cross-sectional study. Methods: Insulin Tolerance Test (ITT), IGF-I and IGFBP-3 levels, Thyroid and gonadal function, serum sodium and metabolic profiles were investigated in 30 childhood onset ALL survivors. (16 males, 14 females, mean age: 14.66 ± 7.16 years). Results: Endocrine abnormalities were displayed in 73.33 % of patients, 46.7% had two or more abnormalities. Grade3 of severity were present in 16.67%. Growth hormone deficiency (GHD) was detected in 10 patients (33%). Early onset of ALL was the potential risk factor of GHD. Adult height was more deteriorated in the female group. Twenty percent of patients were found with subnormal cortisol responses. Gonadal failure was evidenced in one case that experienced testicular irradiation. No diabetes insipidus was detected. Among 6 obese patients, 2 patients developed metabolic syndrome. Moreover, one patient was diagnosed with insulin-depleted diabetes mellitus. Conclusion: Our results highlighted various endocrine and metabolic sequelae occurring in childhood-onset ALL survivors after completion of their therapy. The prevalence of GHD was higher than the one previously described in Japan population. Subclinical hormonal abnormalities may affect health outcomes. Biochemical and hormonal abnormalities should be carefully monitored for immediate treatment.
Publikationsverlauf
Eingereicht: 28. November 2019
Angenommen: 19. Juni 2020
Artikel online veröffentlicht:
17. Mai 2021
© 2020. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Seksarn P, Wiangnon S, Veerakul G, Chotsampancharoen T, Kanjanapongkul S, Chainansamit SO. Outcome of childhood acute lymphoblastic leukemia treated using the Thai national protocols. Asian Pac J Cancer Prev 2015; 16: 4609-14
- 2 Rose SR, Horne VE, Howell J, Lawson SA, Rutter MM, Trotman GE. et al. Late endocrine effects of childhood cancer. Nat Rev Endocrinol 2016; 12: 319-36
- 3 Chemaitilly W, Cohen LE. Diagnosis of endocrine disease: Endocrine late-effects of childhood cancer and its treatments. Eur J Endocrinol 2017; 176: R183-203
- 4 Ward E, DeSantis C, Robbins A, Kohler B, Jemal A. Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin 2014; 64: 83-103
- 5 Rose SR, Schreiber RE, Kearney NS, Lustig RH, Danish RK, Burghen GA. et al. Hypothalamic dysfunction after chemotherapy. J Pediatr Endocrinol Metab 2004; 17: 55-66
- 6 Gurney JG, Ness KK, Sibley SD, O'Leary M, Dengel DR, Lee JM. et al. Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia. Cancer 2006; 107: 1303-12
- 7 Vilela MI, Serravite Mde O, Oliveira NB, de Brito PC, Ribeiro-Oliveira Jr A, Viana MB. Height deficit and impairment of the GH/IGF-1 axis in patients treated for acute lymphoblastic leukemia during childhood. Horm Res Paediatr 2013; 79: 9-16
- 8 Follin C, Wiebe T, Moëll C, Erfurth EM. Moderate dose cranial radiotherapy causes central adrenal insufficiency in long-term survivors of childhood leukaemia. Pituitary 2014; 17: 7-12
- 9 Gordijn MS, van Litsenburg RR, Gemke RJ, Bierings MB, Hoogerbrugge PM, van de Ven PM. et al. Hypothalamic-pituitary-adrenal axis function in survivors of childhood acute lymphoblastic leukemia and healthy controls. Psychoneuroendocrinology 2012; 37: 1448-56
- 10 Elitzur S, Houri-Shtrecher R, Yackobovitz-Gavan M, Avrahami G, Barzilai S, Gilad G. et al. Growth and pubertal patterns in young survivors of childhood acute lymphoblastic leukemia. J Pediatr Endocrinol Metab 2017; 30: 869-77
- 11 Zhang FF, Rodday AM, Kelly MJ, Must A, MacPherson C, Roberts SB. et al. Predictors of being overweight or obese in survivors of pediatric acute lymphoblastic leukemia (ALL). Pediatr Blood Cancer 2014; 61: 1263-9
- 12 Hata M, Ogino I, Aida N, Saito K, Omura M, Kigasawa H. et al. Prophylactic cranial irradiation of acute lymphoblastic leukemia in childhood: Outcomes of late effects on pituitary function and growth in long-term survivors. Int J Cancer 2001; 96 Suppl: 117-24
- 13 Han JW, Kwon SY, Won SC, Shin YJ, Ko JH, Lyu CJ. Comprehensive clinical follow-up of late effects in childhood cancer survivors shows the need for early and well-timed intervention. Ann Oncol 2009; 20: 1170-7
- 14 Han JW, Kim HS, Kim BS, Kwon SY, Shin YJ, Kim SH. et al. Increasing and worsening late effects in childhood cancer survivors during follow-up. J Korean Med Sci 2013; 28: 755-62
- 15 Zareifar S, Haghpanah S, Shorafa E, Shakibazad N, Karamizadeh Z. Evaluation of metabolic syndrome and related factors in children affected by acute lymphoblastic leukemia. Indian J Med Paediatr Oncol 2017; 38: 97-102
- 16 Ting Cheung Y. Cancer pharmacoethnicity: Ascertaining chronic health outcomes in survivors of childhood cancer in Asia. Glob J Pharmaceu Sci 2017; 4: 555634
- 17 Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: International survey. BMJ 2000; 320: 1240-3
- 18 Greulich WW, Pyle SI, Todd TW. Radiographic Atlas of Skeletal Development of the Hand and Wrist. California: Stanford University Press; 1950
- 19 Bayley N, Pinneau SR. Tables for predicting adult height from skeletal age: Revised for use with the Greulich-Pyle hand standards. J Pediatr 1952; 40: 423-41
- 20 National Health Foundation. Report of National Health Survey by Physical Measurement, phase II. Thailand: Ministry of Public Health; 1997
- 21 Clayton PE, Cuneo RC, Juul A, Monson JP, Shalet SM, Tauber M. et al. Consensus statement on the management of the GH-treated adolescent in the transition to adult care. Eur J Endocrinol 2005; 152: 165-70
- 22 Babson AL, Olson DR, Palmieri T, Ross AF, Becker DM, Mulqueen PJ. The IMMULITE assay tube: A new approach to heterogeneous ligand assay. Clin Chem 1991; 37: 1521-2
- 23 Elmlinger MW, Kühnel W, Weber MM, Ranke MB. Reference ranges for two automated chemiluminescent assays for serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3). Clin Chem Lab Med 2004; 42: 654-64
- 24 American Diabetes A. Diagnosis and classification of diabetes mellitus. Diabetes Care 2011; 34 Suppl 1: S62-9
- 25 Zimmet P, Alberti KG, Kaufman F, Tajima N, Silink M, Arslanian S. et al. The metabolic syndrome in children and adolescents An IDF consensus report. Pediatr Diabetes 2007; 8: 299-306
- 26 U.S. Department of Health and Human Services: National Institutes of Health and National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0; 2017. https://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm#ctc_50. Available from: [last accessed on 2019 Jun 03]
- 27 Chemaitilly W, Li Z, Huang S, Ness KK, Clark KL, Green DM. et al. Anterior hypopituitarism in adult survivors of childhood cancers treated with cranial radiotherapy: A report from the St Jude Lifetime Cohort study. J Clin Oncol 2015; 33: 492-500
- 28 Ness KK, Baker KS, Dengel DR, Youngren N, Sibley S, Mertens AC. et al. Body composition, muscle strength deficits and mobility limitations in adult survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 2007; 49: 975-81
- 29 Jaruratanasirikul S, Owasith K, Wongchanchailert M, Laosombat V, Sriplung H. Growth patterns and final height of survivors of childhood leukemia. J Pediatr Endocrinol Metab 2004; 17: 719-26
- 30 Lando A, Holm K, Nysom K, Rasmussen AK, Feldt-Rasmussen U, Petersen JH. et al. Thyroid function in survivors of childhood acute lymphoblastic leukaemia: The significance of prophylactic cranial irradiation. Clin Endocrinol (Oxf) 2001; 55: 21-5
- 31 Baronio F, Battisti L, Radetti G. Central hypothyroidism following chemotherapy for acute lymphoblastic leukemia. J Pediatr Endocrinol Metab 2011; 24: 903-6
- 32 Rutter MM, Rose SR. Long-term endocrine sequelae of childhood cancer. Curr Opin Pediatr 2007; 19: 480-7
- 33 Darzy KH, Shalet SM. Absence of adrenocorticotropin (ACTH) neurosecretory dysfunction but increased cortisol concentrations and production rates in ACTH-replete adult cancer survivors after cranial irradiation for nonpituitary brain tumors. J Clin Endocrinol Metab 2005; 90: 5217-25
- 34 Borson-Chazot F, Brue T. Pituitary deficiency after brain radiation therapy. Ann Endocrinol (Paris) 2006; 67: 303-9
- 35 Gleeson HK, Shalet SM. The impact of cancer therapy on the endocrine system in survivors of childhood brain tumours. Endocr Relat Cancer 2004; 11: 589-602
- 36 Meacham LR, Gurney JG, Mertens AC, Ness KK, Sklar CA, Robison LL. et al. Body mass index in long-term adult survivors of childhood cancer: A report of the Childhood Cancer Survivor Study. Cancer 2005; 103: 1730-9
- 37 Earl M. Incidence and management of asparaginase-associated adverse events in patients with acute lymphoblastic leukemia. Clin Adv Hematol Oncol 2009; 7: 600-6